Evidence map›Paper›PMID 41022449›Full record

ArticleBMJ open2025

Determining the indirect costs of suicide in Sweden: a national population-based cross-sectional study, 2010-2019.

Daniela Wikström, Camilla Nystrand, Gergö Hadlaczky, Filip Gedin

Abstract read
In one paragraph

Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Daniela WikströmDepartment of Learning, Informatics, Management and Ethics, Karolinska Institutet, Stockholm, Sweden.
Camilla NystrandDepartment of Learning, Informatics, Management and Ethics, Karolinska Institutet, Stockholm, Sweden.
Gergö HadlaczkyDepartment of Learning, Informatics, Management and Ethics, Karolinska Institutet, Stockholm, Sweden.
Filip GedinDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden Filip.gedin@ki.se.ORCID http://orcid.org/0000-0002-8408-5106

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesGlobally, more than 700 000 people commit suicide annually. In Sweden, the yearly incidence ranges between 1000 and 1500 people, which is higher than the global average. The aim of this study is to estimate the economic burden related to indirect costs that suicide has imposed on Swedish society between 2010 and 2019.

designNational population-based cross-sectional study. PARTICIPANTS AND

settingAll suicides in Sweden between 2010 and 2019, using data from the Swedish National Cause of Death Registry. OUTCOMES: Indirect costs associated with suicides, estimated using the human capital approach, including productivity loss over 1-year and lifetime horizons.

resultsBetween 2010 and 2019, 1406 to 1591 suicides occurred annually in Sweden, resulting in approximately 26 500 productive life years lost each year. In 2019, the productivity loss due to suicides was estimated at €44 million over a 1-year horizon and €935 million over a lifetime horizon. The corresponding per-person costs were €37 000 and €778 000, respectively.

conclusionsThis study provides valuable insights into the economic burden of suicide on Swedish society. It underlines the potential economic benefits of effective suicide prevention, aligning with previous research highlighting the substantial returns-both monetary and in terms of human well-being-that successful prevention strategies can yield.

Indexed as

Cost of IllnessSuicideAdolescentAdultAgedCross-Sectional StudiesFemaleHumansMaleMiddle AgedRegistriesSwedenYoung AdultHEALTH ECONOMICSPREVENTIVE MEDICINEPublic healthSuicide & self-harm

Identifiers

PMID41022449
PMCPMC12481339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.